Angiotensin II type 1 receptor antagonists alleviate muscle pathology in the mouse model for laminin-α2-deficient congenital muscular dystrophy (MDC1A)

BACKGROUND: Laminin-α2-deficient congenital muscular dystrophy (MDC1A) is a severe muscle-wasting disease for which no curative treatment is available. Antagonists of the angiotensin II receptor type 1 (AT1), including the anti-hypertensive drug losartan, have been shown to block also the profibroti...

Descripción completa

Detalles Bibliográficos
Autores principales: Meinen, Sarina, Lin, Shuo, Ruegg, Markus A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3598380/
https://www.ncbi.nlm.nih.gov/pubmed/22943509
http://dx.doi.org/10.1186/2044-5040-2-18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3598380/
https://www.ncbi.nlm.nih.gov/pubmed/22943509
http://dx.doi.org/10.1186/2044-5040-2-18

Ejemplares similares